October 02, 2023
A clinical diagnostic test supplier will pay $32.5 million to resolve allegations that it violated the False Claims Act by skirting Medicare rules to overbill the federal government for genomic-based lab tests for cancer patients, the U.S. Attorney's Office for the Eastern District of New York announced on Monday.